Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 163


Successful Introduction of Peritoneal Dialysis in an End-stage Renal Failure Patient with Idiopathic Aplastic Anemia.

Suzuki Y, Mizuno M, Sakata F, Kojima H, Sato Y, Kishimoto M, Suzuki N, Kinashi H, Saito S, Katsuno T, Kosugi T, Maruyama S, Murata M, Kiyoi H, Ito Y.

Intern Med. 2020;59(5):683-687. doi: 10.2169/internalmedicine.3775-19. Epub 2020 Mar 1.


Oral Administration of Fucoidan Can Exert Anti-Allergic Activity after Allergen Sensitization by Enhancement of Galectin-9 Secretion in Blood.

Mizuno M, Sakaguchi K, Sakane I.

Biomolecules. 2020 Feb 9;10(2). pii: E258. doi: 10.3390/biom10020258.


Contents and Intensity of Services in Low- and High-Fidelity Programs for Supported Employment: Results of a Longitudinal Survey.

Yamaguchi S, Mizuno M, Sato S, Matsunaga A, Sasaki N, Shimodaira M, Fujii C.

Psychiatr Serv. 2020 Jan 3:appips201900255. doi: 10.1176/ [Epub ahead of print]


Connective tissue growth factor is correlated with peritoneal lymphangiogenesis.

Kinashi H, Toda N, Sun T, Nguyen TQ, Suzuki Y, Katsuno T, Yokoi H, Aten J, Mizuno M, Maruyama S, Yanagita M, Goldschmeding R, Ito Y.

Sci Rep. 2019 Aug 21;9(1):12175. doi: 10.1038/s41598-019-48699-9.


HIV-associated Immune Complex Kidney Disease with C3-dominant Deposition Induced by HIV Infection after Treatment of IgA Nephropathy.

Kawakita C, Kinomura M, Otaka N, Kitagawa M, Sugiyama H, Kusano N, Mizuno M, Wada J.

Intern Med. 2019 Oct 15;58(20):3001-3007. doi: 10.2169/internalmedicine.2439-18. Epub 2019 Jun 27.


The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockers.

Fukuda M, Isobe-Sasaki Y, Sato R, Miura T, Mizuno M, Ono M, Kiyono K, Yamamoto Y, Hayano J, Ohte N.

J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320319839525. doi: 10.1177/1470320319839525.


Excessive salt intake increases peritoneal solute transport rate via local tonicity-responsive enhancer binding protein in subtotal nephrectomized mice.

Sun T, Sakata F, Ishii T, Tawada M, Suzuki Y, Kinashi H, Katsuno T, Takei Y, Maruyama S, Mizuno M, Ito Y.

Nephrol Dial Transplant. 2019 Dec 1;34(12):2031-2042. doi: 10.1093/ndt/gfz045.


Mouse NC/Jic strain provides novel insights into host genetic factors for malaria research.

Ohno T, Miyasaka Y, Kuga M, Ushida K, Matsushima M, Kawabe T, Kikkawa Y, Mizuno M, Takahashi M.

Exp Anim. 2019 Aug 14;68(3):243-255. doi: 10.1538/expanim.18-0185. Epub 2019 Mar 15. Review.


Increase of Eosinophil in Dialysate During Induction of Peritoneal Dialysis.

Shigemoto E, Mizuno M, Suzuki Y, Kobayashi K, Sakata F, Kariya T, Katsuno T, Maruyama S, Ito Y.

Perit Dial Int. 2019 Jan-Feb;39(1):90-92. doi: 10.3747/pdi.2017.00205.


Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats.

Oshima H, Miki T, Kuno A, Mizuno M, Sato T, Tanno M, Yano T, Nakata K, Kimura Y, Abe K, Ohwada W, Miura T.

J Pharmacol Exp Ther. 2019 Mar;368(3):524-534. doi: 10.1124/jpet.118.253666. Epub 2018 Dec 14.


Effects of long-term treatment with low-GDP, pH-neutral solutions on peritoneal membranes in peritoneal dialysis patients.

Tawada M, Hamada C, Suzuki Y, Sakata F, Sun T, Kinashi H, Katsuno T, Takei Y, Maruyama S, Honda K, Mizuno M, Ito Y.

Clin Exp Nephrol. 2019 May;23(5):689-699. doi: 10.1007/s10157-018-1679-7. Epub 2018 Dec 13.


Pleurotus citrinopileatus polysaccharide stimulates anti-inflammatory properties during monocyte-to-macrophage differentiation.

Minato KI, Laan LC, van Die I, Mizuno M.

Int J Biol Macromol. 2019 Feb 1;122:705-712. doi: 10.1016/j.ijbiomac.2018.10.157. Epub 2018 Oct 27.


Anti-C5a complementary peptide mitigates zymosan-induced severe peritonitis with fibrotic encapsulation in rats pretreated with methylglyoxal.

Iguchi D, Mizuno M, Suzuki Y, Sakata F, Maruyama S, Okada A, Okada H, Ito Y.

Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1732-F1746. doi: 10.1152/ajprenal.00172.2018. Epub 2018 Oct 3.


Current Status of Peritoneal Dialysis in Japan.

Ito Y, Tawada M, Tine S, Mizuno M, Suzuki Y, Katsuno T.

Contrib Nephrol. 2018;196:123-128. doi: 10.1159/000485711. Epub 2018 Jul 24. Review.


Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.

Clin Exp Nephrol. 2019 Jan;23(1):112-121. doi: 10.1007/s10157-018-1610-2. Epub 2018 Jul 23.


Differences in peritoneal solute transport rates in peritoneal dialysis.

Asano M, Ishii T, Hirayama A, Mizuno M, Suzuki Y, Sakata F, Akiyama SI, Maruyama S, Soga T, Kinashi H, Katsuno T, Ito Y.

Clin Exp Nephrol. 2019 Jan;23(1):122-134. doi: 10.1007/s10157-018-1611-1. Epub 2018 Jul 2.


Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.

Clin Exp Nephrol. 2019 Jan;23(1):65-75. doi: 10.1007/s10157-018-1609-8. Epub 2018 Jun 29.


Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.

Mizuno M, Kuno A, Yano T, Miki T, Oshima H, Sato T, Nakata K, Kimura Y, Tanno M, Miura T.

Physiol Rep. 2018 Jun;6(12):e13741. doi: 10.14814/phy2.13741.


Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis.

Katsuno T, Ozaki T, Ozeki T, Hachiya A, Kim H, Kato N, Ishimoto T, Kato S, Kosugi T, Tsuboi N, Mizuno M, Ito Y, Maruyama S.

Clin Exp Nephrol. 2018 Dec;22(6):1341-1350. doi: 10.1007/s10157-018-1590-2. Epub 2018 May 23.


Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus.

Nakata K, Miki T, Tanno M, Ohnishi H, Yano T, Muranaka A, Sato T, Oshima H, Tatekoshi Y, Mizuno M, Abe K, Miura T.

PLoS One. 2017 Dec 19;12(12):e0188689. doi: 10.1371/journal.pone.0188689. eCollection 2017.

Supplemental Content

Loading ...
Support Center